Novartis: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
Global PDF: US$ 3,900.00
A strategic assessment of Novartis, one of the world’s leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global pharmaceutical market.
Contains 140 pages and 11 tables
A strategic assessment of Novartis, one of the world’s leading pharmaceutical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global pharmaceutical market.
Contains 140 pages and 11 tables
I. EXECUTIVE SUMMARY
II. BUSINESS ORGANIZATION
III. SENIOR MANAGEMENT
IV. FACILITIES AND EMPLOYEES
V. TECHNOLOGICAL KNOW-HOW
VI. PRODUCT PORTFOLIO
VII. MARKETING TACTICS
VIII. SALES AND PROFIT GROWTH
IX. R&D EXPENDITURES AND MAJOR PROGRAMS
X. COLLABORATIVE ARRANGEMENTS
XI. STRATEGIC DIRECTION
LIST OF TABLES
Table 1: Novartis Sales and Operating Profit Growth
Table 2: Novartis Sales by Business Segment
Table 3: Novartis Sales Growth by Business Segment
Table 4: Novartis Operating Profit by Business Segment
Table 5: Novartis Operating Profit Growth by Business Segment
Table 6: Novartis Sales by Country
Table 7: Novartis Sales Growth by Country
Table 8: Novartis Sales by Therapeutic Category
Table 9: Novartis Sales Growth by Therapeutic Category
Table 10: Novartis Sales of Top 20 Drugs
Table 11: Novartis Sales Growth by Major Drug
II. BUSINESS ORGANIZATION
III. SENIOR MANAGEMENT
IV. FACILITIES AND EMPLOYEES
V. TECHNOLOGICAL KNOW-HOW
VI. PRODUCT PORTFOLIO
VII. MARKETING TACTICS
VIII. SALES AND PROFIT GROWTH
IX. R&D EXPENDITURES AND MAJOR PROGRAMS
X. COLLABORATIVE ARRANGEMENTS
XI. STRATEGIC DIRECTION
LIST OF TABLES
Table 1: Novartis Sales and Operating Profit Growth
Table 2: Novartis Sales by Business Segment
Table 3: Novartis Sales Growth by Business Segment
Table 4: Novartis Operating Profit by Business Segment
Table 5: Novartis Operating Profit Growth by Business Segment
Table 6: Novartis Sales by Country
Table 7: Novartis Sales Growth by Country
Table 8: Novartis Sales by Therapeutic Category
Table 9: Novartis Sales Growth by Therapeutic Category
Table 10: Novartis Sales of Top 20 Drugs
Table 11: Novartis Sales Growth by Major Drug
